Published in J Control Release on December 06, 1999
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology (2006) 1.92
Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses. Immunology (2002) 1.04
Nanoparticulate adjuvants and delivery systems for allergen immunotherapy. J Biomed Biotechnol (2012) 0.87
The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol (1971) 4.67
The effects of recall on estimating annual nonfatal injury rates for children and adolescents. Am J Public Health (1994) 4.60
The epidemiology of nonfatal injuries among US children and youth. Am J Public Health (1995) 3.93
Differences in immune elimination in inbred mice. The role of low affinity antibody. Clin Exp Immunol (1972) 3.03
The use of ammonium sulphate globulin precipitation for determination of affinity of anti-protein antibodies in mouse serum. Immunology (1972) 3.00
Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim Biophys Acta (1974) 2.77
Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature (1995) 2.68
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
DNA mutagenesis and recombination. Nature (1990) 2.45
Enhancement of recovery from psychiatric illness by methylfolate. Br J Psychiatry (1992) 2.44
Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet (1992) 2.31
An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J Immunol Methods (1988) 2.27
The heterogeneity of antibody affinity in inbred mice and its possible immunopathologic significance. Clin Exp Immunol (1972) 2.04
The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Methods (1985) 1.89
The role of low affinity antibody in immune complex disease. The quantity of anti-DNA antibodies in NZB/W F1 hybrid mice. Clin Exp Immunol (1975) 1.81
Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin Exp Immunol (1976) 1.77
The genetic control of antibody affinity in mice. Immunology (1975) 1.75
Chronic immune complex disease in mice: the role of antibody affinity. Clin Exp Immunol (1979) 1.70
Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA (1993) 1.69
Treatment of extramammary Paget's disease by radiotherapy. Br J Dermatol (1995) 1.67
Two routes for 99mTc-DMSA uptake into the renal cortical tubular cell. Eur J Nucl Med (1988) 1.66
Inter-mouse strain differences in macrophage function and its relationship to antibody responses. Clin Exp Immunol (1974) 1.65
The antigen-binding characteristics of antibody pools of different relative affinity. Immunology (1972) 1.64
The induction of chronic antigen-antibody complex disease in selectively bred mice producing either high or low affinity antibody to protein antigens. Immunology (1980) 1.55
Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl (1992) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet (1984) 1.47
Role of venous sampling in locating a phaeochromocytoma. Br Med J (Clin Res Ed) (1983) 1.45
The use of a double isotope method in the determination of antibody affinity. J Immunol Methods (1973) 1.45
t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci U S A (1998) 1.41
Two distinct classes of IgG Fc receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength. J Immunol (1985) 1.41
Linear sebaceous naevus syndrome and resistant rickets. J Bone Joint Surg Br (2003) 1.41
Lingual tonsillar hypertrophy causing failed intubation and cerebral anoxia. Am J Forensic Med Pathol (1993) 1.41
Primary cutaneous neuroendocrine (Merkel cell or trabecular carcinoma) tumour of the skin: a radioresponsive tumour. Clin Radiol (1989) 1.40
Relative affinity of anti-protein antibodies in New Zealand mice. Clin Exp Immunol (1972) 1.39
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med (1992) 1.38
Incorporation of 5-methylorcylaldehyde and methionine into the acetogenin (polyketide) gliorosein in Gliocladium roseum I.M.I. 93065. Biochem J (1968) 1.38
NMR experiments on aligned samples of membrane proteins. Methods Enzymol (2005) 1.34
IgG subclass-associated affinity differences of specific antibodies in humans. J Immunol (1988) 1.33
The effects of protein malnutrition on macrophage function and the amount and affinity of antibody response. Clin Exp Immunol (1974) 1.33
An ELISA to detect monoclonal antibodies specific for lipid determinants of Mycoplasma pneumoniae. J Immunol Methods (1983) 1.31
Resistance of rabbit secretory IgA to proteolysis. Biochim Biophys Acta (1971) 1.31
Macrophage clearance function and immune complex disease in New Zealand Black/White F1 hybrid mice. Clin Exp Immunol (1976) 1.30
Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc Natl Acad Sci U S A (2000) 1.29
The measurement of antibody affinity: a comparison of five techniques utilizing a panel of monoclonal anti-DNP antibodies and the effect of high affinity antibody on the measurement of low affinity antibody. J Immunol Methods (1983) 1.28
Molecular characterization of Mycoplasma genitalium species-specific and cross-reactive determinants: identification of an immunodominant protein of M. genitalium. Isr J Med Sci (1987) 1.28
Trauma services requirements in a district general hospital serving a rural area. BMJ (1990) 1.26
A dose-response study of I3-cis-retinoic acid in acne vulgaris. Br J Dermatol (1983) 1.23
Behavioral risk factors in an Amish community. Am J Prev Med (1989) 1.22
Failure of affinity maturation leads to increased susceptibility to immune complex glomerulonephritis. Immunology (1984) 1.21
Immunohistochemical localization of neurofilament antigen in rat cerebellum. J Neurocytol (1979) 1.20
Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J Gen Virol (1990) 1.20
Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol (1998) 1.18
Experimental antigen-antibody complex disease in mice. The role of antibody levels, antibody affinity and circulating antigen-antibody complexes. Int Arch Allergy Appl Immunol (1982) 1.18
The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide. Immunology (1996) 1.17
Measurement of antigen-antibody complexes in mouse sera by conglutinin, C1q and rheumatoid factor solid phase binding assays. J Immunol Methods (1980) 1.16
Evidence for the genetic control of antibody affinity from breeding studies with inbred mouse strains producing high and low affinity antibody. Immunology (1976) 1.15
The effect of malaria on the relative affinity of mouse antiprotein antibody. Br J Exp Pathol (1973) 1.14
Cardiovascular health knowledge in the United States: findings from the National Health Interview Survey, 1985. Prev Med (1991) 1.13
Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet (1992) 1.13
Reversible dissociation of dimeric tyrosyl-tRNA synthetase by mutagenesis at the subunit interface. Biochemistry (1985) 1.12
Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses. J Bone Joint Surg Br (1997) 1.11
The genetic control of antibody affinity. Evidence from breeding studies with mice selectively bred for either high or low affinity antibody production. Immunology (1979) 1.11
Spontaneous mutation, oxidative DNA damage, and the roles of base and nucleotide excision repair in the yeast Saccharomyces cerevisiae. Yeast (1999) 1.10
Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Proc Natl Acad Sci U S A (1997) 1.10
Plasma noradrenaline concentration in essential hypertension during long-term beta-adrenoceptor blockade with oxprenolol. Br J Clin Pharmacol (1980) 1.09
Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization. Mol Immunol (1993) 1.07
A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics (2000) 1.07
Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse. Dev Biol (2000) 1.04
The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Clin Exp Immunol (1995) 1.03
Microcomputer system in an accident unit. Br Med J (Clin Res Ed) (1982) 1.03
Influence of antibody affinity on the performance of different antibody assays. J Immunol Methods (1984) 1.03
Antibody affinity and clearance function studies in high and low antibody affinity mice. The effect of protein deficiency. Immunology (1979) 1.02
Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies. Int J Cancer (1985) 1.02
SEPN1-related myopathies: clinical course in a large cohort of patients. Neurology (2011) 1.02
Determination of the affinity of antibodies to hepatitis B surface antigen in human sera. J Immunol Methods (1984) 1.01
Studies on the genetic control of antibody affinity: the independent control of antibody levels and affinity in Biozzi mice. J Immunol (1976) 1.01
Glomerulonephritis induced by pre-formed immune complexes containing monoclonal antibodies of defined affinity and isotype. Clin Exp Immunol (1984) 1.00
Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res (1992) 1.00
Displaced stress fracture of the femoral neck in an active amenorrhoeic adolescent. Br J Sports Med (1997) 1.00
A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol (1982) 1.00
Phytic acid-metal complexes. Proc Soc Exp Biol Med (1965) 1.00
Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins. J Gen Virol (1991) 0.98
Low molecular weight mercaptoethanol sensitive antibody in rabbits. Immunochemistry (1969) 0.98
Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides. Immunology (1992) 0.98
Socioeconomic and racial/ethnic factors affecting non-fatal medically attended injury rates in US children. Inj Prev (1997) 0.98
Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner gene. Blood (1997) 0.98
Variations in host responses and the pathogenesis of human onchocerciasis. Rev Infect Dis (1986) 0.98
The affinity of anti-HBc antibodies in acute and chronic hepatitis B infection. Clin Exp Immunol (1990) 0.98
Trochanteric fractures of the femur. A randomised prospective trial comparing the Jewett nail-plate with the dynamic hip screw. J Bone Joint Surg Br (1986) 0.98
Does labetalol increase excretion of urinary catecholamines? Br Med J (1978) 0.97
Antibody affinity maturation in selectively bred high and low-affinity mice. Eur J Immunol (1986) 0.97
The significance of antibody affinity heterogeneity in antigen-antibody reactions demonstrated by computer simulation. Mol Immunol (1980) 0.96
Panhandle PCR: a technical advance to amplify MLL genomic translocation breakpoints. Leukemia (1998) 0.96
Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo. Clin Exp Immunol (1983) 0.96
Microtubules, dendritic spines and spine appratuses. Cell Tissue Res (1980) 0.95
Epitope mapping and tagging by recombination PCR mutagenesis. Biotechniques (1997) 0.95
Chronic liver disease: the detection and characterization of circulating immune complexes. Immunology (1983) 0.95
Relative mitogenic activities of wild-type and retinoblastoma binding-defective SV40 T antigens in serum-deprived and senescent human diploid fibroblasts. Oncogene (1993) 0.94
Fc receptor-mediated binding and endocytosis by human mononuclear phagocytes: monomeric IgG is not endocytosed by U937 cells and monocytes. J Cell Biol (1985) 0.94